Correlation Between Compugroup Medical and Synopsys

Can any of the company-specific risk be diversified away by investing in both Compugroup Medical and Synopsys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Compugroup Medical and Synopsys into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Compugroup Medical SE and Synopsys, you can compare the effects of market volatilities on Compugroup Medical and Synopsys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Compugroup Medical with a short position of Synopsys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Compugroup Medical and Synopsys.

Diversification Opportunities for Compugroup Medical and Synopsys

0.38

Correlation Coefficient

Compugroup Medical  Synopsys

Weak diversification

The 3 months correlation between Compugroup and Synopsys is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Compugroup Medical SE and Synopsys in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synopsys and Compugroup Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Compugroup Medical SE are associated (or correlated) with Synopsys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synopsys has no effect on the direction of Compugroup Medical i.e., Compugroup Medical and Synopsys go up and down completely randomly.

Pair Corralation between Compugroup Medical and Synopsys

Assuming the 90 days horizon Compugroup Medical SE is expected to generate 1.89 times more return on investment than Synopsys. However, Compugroup Medical is 1.89 times more volatile than Synopsys. It trades about 0.16 of its potential returns per unit of risk. Synopsys is currently generating about 0.06 per unit of risk. If you would invest  1,380  in Compugroup Medical SE on September 12, 2024 and sell it today you would earn a total of  778.00  from holding Compugroup Medical SE or generate 56.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Compugroup Medical SE  vs.  Synopsys

Compugroup Medical

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Compugroup Medical SE are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Compugroup Medical reported solid returns over the last few months and may actually be approaching a breakup point.

Synopsys

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Synopsys are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Synopsys may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Compugroup Medical and Synopsys

The main advantage of trading using opposite Compugroup Medical and Synopsys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Compugroup Medical position performs unexpectedly, Synopsys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synopsys will offset losses from the drop in Synopsys' long position.

The idea behind Compugroup Medical SE and Synopsys pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.